NEWS
Latest Updates from MetiMedi Pharmaceuticals.
News & Media
[20.11.16] Phase 1 Clinical Trial Abstract and Poster Submission Completed
- 2025-09-22
- View 36
We have completed submitting the poster to
the Korean Cancer Society.
썸네일 MetiMedi_Signature Logo.png (대표)
